Steven Everett, MBA, Ph.D.

Steven Everett 1

Steven Everett is a seasoned biotechnology executive and scientific leader with 25 years of experience in managing drug discovery and development programs as well as business development opportunities in world-renowned academic institutions and biotech companies, with deep experience in oncology, venture capital financing, and strategic partnership generation. His passion is in the exploitation of cutting-edge […]

Craig Coburn, Ph.D.

Craig Coburn 1

An accomplished research and development leader with 30 years of experience. 2017 American Chemical Society Hero of Chemistry. Inventor of Merck’s HCV NS5A replication complex inhibitor Elbasvir (MK-8742) and responsible for the nomination and development of multiple clinical compounds that span the cardiovascular, neuroscience, oncology and infectious disease therapeutic areas. Built, developed and motivated a […]

Rick Panicucci, Ph.D.

Rick Panicucci 2

Rick Panicucci, Ph.D., is Co-founder of MaveriX Oncology and has been involved with the company since incorporation in 2016.  Rick currently holds the position of Senior Vice President of CMC at BridgeBio and has held a number of senior leadership roles in drug and business development in the pharmaceutical industry over the past 25 years. […]